Immunosuppressants Global Market Report 2023

Feb 2023| TBR1170D| TBRC (Publisher)

Sample Report

Report Highlights

Including: 1) By Drug Class: Corticosteroids; Monoclonal Antibodies (mAbs); Calcineurin Inhibitors; mTOR Inhibitors; Anti-Proliferative Agents
2) By Indication: Organ Transplantation; Autoimmune Disorders; Non-Autoimmune Inflammatory Diseases
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Covering: Astellas Pharma; GlaxoSmithKline; Bristol Myers Squibb; Johnson & Johnson; Intas Pharmaceuticals Ltd.

Immunosuppressants Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunosuppressants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:
Where is the largest and fastest growing market for immunosuppressants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The immunosuppressants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Report Synopsis

Report Metrics	Details
Base year considered	2022
Forecast period considered	2022-2032
Units considered	$ Billion
Segments covered	By Drug Class, By Indication, By Distribution Channel
Industry covered	Pharmaceuticals
Regions covered	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Countries covered	Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
Companies studied	Astellas Pharma Accord Healthcare GlaxoSmithKline Bristol Myers Squibb Johnson & Johnson Intas Pharmaceuticals Ltd. Mylan Laboratories Inc. Novartis Sanofi S.A F. Hoffmann La Roche Ltd. Zydus Cadila RPG Life Sciences Limited Pfizer Genzyme AbbVie Inc. Glenmark Pharmaceuticals Akriti Pharmaceuticals Pvt. Allergan SEBELA PHARMACEUTICALS INC. Healthy Life Pharma Private Limited

Scope

Markets Covered:

By Drug Class: Corticosteroids; Monoclonal Antibodies (mAbs); Calcineurin Inhibitors; mTOR Inhibitors; Anti-Proliferative Agents; Other Drug Classes
By Indication: Organ Transplantation; Autoimmune Disorders; Non-Autoimmune Inflammatory Diseases
By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Companies Mentioned: Astellas Pharma; GlaxoSmithKline; Bristol Myers Squibb; Johnson & Johnson; Intas Pharmaceuticals Ltd.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Table 1 : Global Historic Market Growth, 2017-2022, $ Billion
Table 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3 : Global Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4 : Global Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5 : Global Immuno Suppressive Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 6 : Global Immuno Suppressive Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 7 : Global Immuno Suppressive Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 8 : Asia-Pacific, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 9 : Asia-Pacific, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 10 : China, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 11 : China, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 12 : India, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 13 : India, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 14 : Japan, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 15 : Japan, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 16 : Australia, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 17 : Australia, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 18 : Indonesia, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 19 : Indonesia, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 20 : South Korea, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 21 : South Korea, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 22 : Western Europe, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 23 : Western Europe, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 24 : UK, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 25 : UK, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 26 : Germany, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 27 : Germany, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 28 : France, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 29 : France, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 30 : Eastern Europe, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 31 : Eastern Europe, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 32 : Russia, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 33 : Russia, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 34 : North America, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 35 : North America, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 36 : USA, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 37 : USA, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 38 : South America, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 39 : South America, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 40 : Brazil, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 41 : Brazil, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 42 : Middle East, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 43 : Middle East, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 44 : Africa, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 45 : Africa, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 46 : Astellas Pharma Financial Performance
Table 47 : GlaxoSmithKline Financial Performance
Table 48 : Bristol Myers Squibb Financial Performance
Table 49 : Johnson & Johnson Financial Performance
Table 50 : Intas Pharmaceuticals Ltd. Financial Performance

Figure 1 : Global Historic Market Growth, 2017-2022, $ Billion
Figure 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Figure 3 : Global Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 4 : Global Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 5 : Global Immuno Suppressive Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 6 : Global Immuno Suppressive Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 7 : Global Immuno Suppressive Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 8 : Asia-Pacific, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 9 : Asia-Pacific, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 10 : China, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 11 : China, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 12 : India, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 13 : India, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 14 : Japan, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 15 : Japan, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 16 : Australia, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 17 : Australia, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 18 : Indonesia, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 19 : Indonesia, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 20 : South Korea, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 21 : South Korea, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 22 : Western Europe, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 23 : Western Europe, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 24 : UK, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 25 : UK, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 26 : Germany, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 27 : Germany, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 28 : France, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 29 : France, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 30 : Eastern Europe, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 31 : Eastern Europe, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 32 : Russia, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 33 : Russia, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 34 : North America, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 35 : North America, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 36 : USA, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 37 : USA, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 38 : South America, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 39 : South America, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 40 : Brazil, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 41 : Brazil, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 42 : Middle East, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 43 : Middle East, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 44 : Africa, Immuno Suppressive Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 45 : Africa, Immuno Suppressive Drugs Market, Segmentation By Indication, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 46 : Astellas Pharma Financial Performance
Figure 47 : GlaxoSmithKline Financial Performance
Figure 48 : Bristol Myers Squibb Financial Performance
Figure 49 : Johnson & Johnson Financial Performance
Figure 50 : Intas Pharmaceuticals Ltd. Financial Performance

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Immunosuppressants Global Market Report 2022

Published Date - Mar 2022
Report Code - TBR1170C

Including: 1) By Drug Class: Corticosteroids; Monoclonal Antibodies (mAbs); Calcineurin Inhibitors; mTOR Inhibitors; Anti-Proliferative Agents; Others
2) By Indication: Organ Transplantation; Autoimmune Disorders; Non-Autoimmune Inflammatory Diseases
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Covering: Astellas Pharma; GlaxoSmithKline; Bristol Myers Squibb; Johnson & Johnson; Intas Pharmaceuticals Ltd.; Mylan Laboratories inc.

Immunosuppressants Global Market Report 2022 from ...

Immunosuppressants Global Market Report 2021: COVID-19 Growth And Change To 2030

Published Date - Sep 2021
Report Code - TBR1170B

Including: 1) By Drug Class: Corticosteroids; Monoclonal Antibodies (mAbs); Calcineurin Inhibitors; mTOR Inhibitors; Anti-Proliferative Agents; Others
2) By Indication: Organ Transplantation; Autoimmune Disorders; Non-Autoimmune Inflammatory Diseases
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Covering: Astellas Pharma; GlaxoSmithKline; Bristol Myers Squibb; Johnson & Johnson; Intas Pharmaceuticals Ltd.

Immunosuppressants Global Market Report 2021: COVID-19 Growth And Change ...

Immunosuppressants Global Market Report 2020-30: COVID-19 Growth and Change

Published Date - Dec 2020
Report Code - TBR1170A

Including: 1) By Drug Class: Corticosteroids; Monoclonal Antibodies (mAbs); Calcineurin Inhibitors; mTOR Inhibitors; Anti-Proliferative Agents; Others

2) By Indication: Organ Transplantation; Autoimmune Disorders; Non-Autoimmune Inflammatory Diseases
3) By Distribution Channel: Hospital pharmacies; Retail pharmacies; Online pharmacies

Covering: Astellas Pharma; GlaxoSmithKline; Bristol Myers Squibb; Johnson & Johnson; Intas Pharmaceuticals Ltd.

Immunosuppressants Global Market Report 2020-30: Covid 19 Growth And Change from ...